Safety, efficacy and pharmacokinetics of interferon alfa-2B and ribavirin in children with chronic hepatitis C.

被引：0
|
作者：
Bunn, S [1 ]
Kelly, D [1 ]
Murray, KF [1 ]
Shelton, M [1 ]
Olson, A [1 ]
Mieli-Vergani, G [1 ]
Zambas, D [1 ]
Gupta, SK [1 ]
Glue, P [1 ]
机构：
[1] Spri, Kenilworth, NJ USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
763
引用
收藏
页码：350A / 350A
页数：1
相关论文
共 50 条
  • [1] Safety, efficacy, and pharmacokinetics of interferon alfa-2b plus ribavirin in children with chronic hepatitis C.
    Kelly, DA
    Bunn, SK
    Apelian, D
    Baczkowski, A
    Gupta, S
    Laughlin, M
    Cohard, M
    HEPATOLOGY, 2001, 34 (04) : 342A - 342A
  • [2] Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children:: Efficacy, safety, and pharmacokinetics
    González-Peralta, RP
    Kelly, DA
    Haber, B
    Molleston, J
    Murray, KF
    Jonas, MM
    Shelton, M
    Mieli-Vergani, G
    Lurie, Y
    Martin, S
    Lang, T
    Baczkowski, A
    Geffner, M
    Gupta, S
    Laughlin, M
    HEPATOLOGY, 2005, 42 (05) : 1010 - 1018
  • [3] Interferon alfa-2b and ribavirin in patients with resistant chronic hepatitis C.
    Min, AD
    Jones, JL
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Esposito, S
    Geders, JM
    Tobias, H
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
  • [4] Cost-effectiveness of ribavirin interferon alfa-2B after interferon relapse in chronic hepatitis C.
    Wong, JB
    Davis, GL
    Pauker, SG
    HEPATOLOGY, 1998, 28 (04) : 591A - 591A
  • [5] Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.
    Wong, JB
    HEPATOLOGY, 2000, 32 (04) : 425A - 425A
  • [6] Impact of interferon alfa-2b and ribavirin on the liver fibrosis progression in patients with chronic hepatitis C.
    Poynard, T
    McHutchinson, J
    Davis, G
    Esteban-Mur, R
    Goodman, Z
    Bedossa, P
    Albrecht, J
    HEPATOLOGY, 1998, 28 (04) : 497A - 497A
  • [7] Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C
    Nagayama, A
    Tanaka, A
    Ankoh, H
    Narita, T
    Izumi, M
    Miyake, K
    Takikawa, H
    HEPATOLOGY RESEARCH, 2005, 32 (02) : 101 - 106
  • [8] Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    MEDICAL SCIENCE MONITOR, 2010, 16 (12): : CR616 - CR621
  • [9] VIROLOGICAL RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON ALFA-2B AND RIBAVIRIN CHRONIC HEPATITIS C IN CHILDREN
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    Jendryczka, Ewa
    HEPATOLOGY, 2008, 48 (04) : 855A - 856A
  • [10] Efficacy and safety of interferon alfa-2b and ribavirin combination therapy in chronic hepatitis C patients: A Czech multicenter study
    Husa, P
    Krtek, V
    Svejda, J
    Stransky, J
    Cieslarova, B
    Nadvornik, V
    Ehrmann, J
    Urbanek, P
    Volfova, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 237 - 237
12345